Novartis, Pfizer cut prices to win UK approval for cancer drugs

LONDON, Nov 10 (Reuters) - Novartis and Pfizer

have won approval for two cancer drugs to be used

routinely on Britain's National Health Service after offering

bigger price discounts.

Read more